Brief: Sanofi, Innate Pharma Expand Collaboration For Natural Killer Cell Therapeutics In Oncology

Innate Pharma SA

19/12/2022 06:07

Dec 19 (Reuters) - Sanofi  SASY.PA :
    * SANOFI AND INNATE PHARMA EXPAND COLLABORATION FOR NATURAL
KILLER
CELL THERAPEUTICS IN ONCOLOGY
    * SANOFI GAINS EXCLUSIVE LICENSE TO INNATE’S B7H3 ANKETTM
PROGRAM
AND OPTIONS FOR TWO ADDITIONAL TARGETS; UPON CANDIDATE
SELECTION, SANOFI WILL BE RESPONSIBLE FOR ALL DEVELOPMENT,
MANUFACTURING AND COMMERCIALIZATION
    * INNATE WILL RECEIVE €25M UPFRONT PAYMENT AND UP TO €1.35BN
TOTAL
IN PRECLINICAL, CLINICAL, REGULATORY AND COMMERCIAL MILESTONES
PLUS ROYALTIES ON POTENTIAL NET SALES

Source text for Eikon:  ID:nGNE6J2BSZ 
Further company coverage:  SASY.PA 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))